RxDoctor Payments Data

George Bodziock, MD

Cardiovascular Disease · Winston Salem, NCNPI 1316392665

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (40.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 57.3% of the total. Reporting peaked in 2022 at $25,174 and has fallen 85.2% since, to $3,737 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,707in general payments, 2019–2025

Across 230 payments — averaging $233.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$31K
  • Abbott$8K
  • Boston Scientific$6K
  • Philips North America LLC$6K
  • Biosense Webster, Inc.$2K
  • Biotronik Inc.$1K
  • plus $447 from 4 others

What the payments were for

  • Consulting fees$4751%
  • Speaking & faculty fees$9002%
  • Grants$21,50040%
  • Travel & lodging$21,20539%
  • Food & beverage$7,60014%
  • Education$2,0274%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,707 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina →

Medicare billing

Part B allowed, 2024
$53,816
Medicare patients
140
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$35,756
Dofetilide13$810
Flecainide Acetate26$583
Amiodarone Hcl15$279
Metoprolol Succinate16$278
Metoprolol Tartrate20$108
Cephalexin12$52

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Winston Salem

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →